Loomis, Sayles & Company
ATHN

Loomis, Sayles & Company’s Athenahealth, Inc. ATHN Stock Holding History

Loomis, Sayles & Company’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-51
Closed -$7K – 916
2018
Q4 		$7K Buy
51
+9
+21% +$1.15K ﹤0.01% 811
2018
Q3 		$6K Buy
+42
New +$6.29K ﹤0.01% 879
2017
Q1 		– Sell
-44,226
Closed -$4.65M – 1072
2016
Q4 		$4.65M Sell
44,226
-697
-2% -$74.9K 0.01% 546
2016
Q3 		$5.67M Buy
44,923
+9,366
+26% +$1.19M 0.01% 504
2016
Q2 		$4.91M Buy
35,557
+22,078
+164% +$2.92M 0.01% 521
2016
Q1 		$1.87M Buy
+13,479
New +$1.85M 0.01% 543
2014
Q2 		– Sell
-2,382
Closed -$382K – 795
2014
Q1 		$382K Sell
2,382
-19,949
-89% -$3.28M ﹤0.01% 607
2013
Q4 		$3M Buy
22,331
+1,823
+9% +$234K 0.01% 582
2013
Q3 		$2.23M Sell
20,508
-7,579
-27% -$819K 0.01% 580
2013
Q2 		$2.38K Buy
+28,087
New +$2.51M 0.01% 564

Loomis, Sayles & Company's ATHN Position: Q1 2019 in Review

Loomis, Sayles & Company sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 51 shares — an estimated $7K sold.

Loomis, Sayles & Company first reported a position in ATHN in Q2 2013 and held it in 10 quarters. The position peaked at $5.67M in Q3 2016. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Loomis, Sayles & Company reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Loomis, Sayles & Company sold 51 Athenahealth, Inc. shares in Q1 2019, an estimated $7K.
  • Loomis, Sayles & Company first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 10 quarters.
  • Loomis, Sayles & Company's Athenahealth, Inc. position peaked at $5.67M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Loomis, Sayles & Company's 13F filing for Q1 2019, filed 15 May 2019.